Transcatheter Interventions Online 2024 - On Demand
Published: 20 March 2024
-
Views:
2802
-
Likes:
7
-
Views:
2802
-
Likes:
7
-
Up Next -
39m 31sPart 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure -
50m 48sPart 1 | Session 5 Session 1.4: Live Cases & Discussions -
1m 46sPart 1 | Session 6 Day One Close
-
3m 9sPart 2 | Session 1 Day Welcome: Complex PCI -
51m 36sPart 2 | Session 2 Session 2.1: Coronary Calcifications Updates -
1h 5m 33sPart 2 | Session 3 Session 2.2: Live Cases & Discussions -
58m 49sPart 2 | Session 4 Session 2.3: Imaging Focus -
1h 5m 56sPart 2 | Session 5 Session 2.4: Live Cases & Discussions -
3m 57sPart 2 | Session 6 Day Two Close
-
2mPart 3 | Session 1 Day Welcome: Debates & Controversies -
1h 1m 13sPart 3 | Session 2 Session 3.1: Keynote & Debates -
55m 15sPart 3 | Session 3 Session 3.2: Live Cases & Discussions -
59m 46sPart 3 | Session 4 Session 3.3: Controversies -
4m 16sPart 3 | Session 5 Day Three Close
-
3m 36sPart 1 | Session 1 Day Welcome: Structural Heart Disease Nicolas M Van Mieghem, Kendra J Grubb, Roxana Mehran, Ajay J Kirtane, David Hildick-Smith, Holger Thiele
-
59m 1sPart 1 | Session 2 Session 1.1: New Perspectives on Transcatheter Atrioventricular Valve Interventions Nicolas M Van Mieghem, Ole De Backer, Kendra J Grubb, Azeem Latib, Didier Tchétché
Overview
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Ole De Backer
Interventional Cardiologist
Prof Ole De Backer is an internationally renowned interventional cardiologist working at Rigshospitalet, Copenhagen University Hospital, Denmark and is an expert in structural heart interventions – among others transcatheter heart valve interventions, percutaneous left atrial appendage closure and thoracic endovascular aortic repair. Special areas of interest are the development and adoption of a fully percutaneous, minimal invasive approach for different structural heart interventions and the use of advanced cardiac imaging tools for planning and guidance of these interventions. He is actively involved and leading several research projects in the field of transcatheter heart valves and percutaneous left atrial appendage closure.
Kendra J Grubb
Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Azeem Latib
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care.
He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.
Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…
Comments